Setup News Ticker
Searching for 'call Inc'. (Return)

Yahoo BusinessMay 24, 2020
Gilead's Remdesivir Most ‘Beneficial' In Covid-19 Patients Who Need Extra Oxygen, Study Shows
Gilead Sciences Inc.'s (GILD) remdesivir, its coronavirus drug candidate, is most "beneficial" for Covid-19 patients who require supplemental oxygen but don't need mechanical ventilation, according to a study by the National Institute of Allergy and Infectious Diseases (NIAID)."Ultimately, the findings support remdesivir as the standard therapy for patients hospitalized with Covid-19 and requiring supplemental oxygen therapy," the report said, citing preliminary results from the randomized, controlled trial, published in The New England Journal of Medicine.Over a 10-day course, patients received the antiviral remdesivir intravenously and a placebo. The report showed that patients who received remdesivir had a shorter time to recovery than those who received placebo. The median time to recovery was 11 days for patients treated with remdesivir compared with 15 days for those who received placebo."These findings support the use of remdesivir in this population, with the largest benefit observed among individuals who required oxygen supplementation but were not mechanically ventilated," said Merdad Parsey, Chief Medical Officer, at Gilead Sciences.Parsey added that Gilead expects results from its Phase 3 SIMPLE-Severe study, which is evaluating experimental remdesivir in a similar population of Covid-19 patients, to be published in the "near future".At the end of this month, Gilead expects to receive results from its Phase 3 SIMPLE-Moder

Yahoo BusinessMay 24, 2020
Twilio To Power New York's COVID-19 Contact Tracing Initiative; Shares Jump 7.5%
Twilio (TWLO) announced that it will provide the communications platform to power New York City's coronavirus contact tracing initiative sending shares up 7.5% on Friday.The cloud communications company said that New York City's Department of Information Technology & Telecommunications (DoITT) is planning to deploy a cloud-based contact center on Twilio Flex to call, message or email COVID-19 patients, educate them on the virus, and identify their close contacts through self-reporting. Terms of the deal weren't disclosed.The platform also provides messaging-based alerts using Twilio Voice, SMS, email or WhatsApp that prompt patients to fill out secure surveys on their symptoms. As governments around the world explore strategies to slow the spread of new coronavirus cases and safely reopen economies, public health departments have identified contact tracing as a step in the process."Throughout this pandemic, the ability for businesses and government agencies to quickly spin up and iterate ways to engage customers and constituents has never been more important," said George Hu, chief operating officer at Twilio. "New York City's contact tracing solution makes it possible for the city to connect with and support residents with COVID-19 and keep their known contacts safe and informed."Twilio stock jumped 7.5% to $208.62 on Friday. The value of the company's shares has almost tripled since mid-March after it posted strong sales figures as the coronavirus-related stay-at-hom
Coronavirusupdates live China Vaccine York
ChinaCoronavirus Hong Kong time will
StockBuy China Dividend Right Market
COVID-19Study During Vaccine Who cases
StocksBuy China Dividend Buying These
HongKong security China law national
KongHong security China law national
Pandemicduring coronavirus how Desperate rats
liveCoronavirus updates national & adviser

Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money Real Estate News Analysis Indicators
Enterprise Application News
Forbes Headlines
Forbes Social Media News - China, Economy & Trade - Financial Markets - Hedge Funds - Telecoms - US
Google Business News
Google Market News
HBS Working Knowledge
INSEAD Knowledge
International Tax Review
L.S. Starrett News
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money Updates: News Digest
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC